ArticleJournal of cardiovascular pharmacology and therapeutics2018

Comparison of LDL-C Reduction Using Different Evolocumab Doses and Intervals: Biological Insights and Treatment Implications.

Scott M Wasserman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.